Potent and effective prolongation by anti-LFA-1 monoclonal antibody monotherapy of non-primarily vascularized heart allograft survival in mice without T cell depletion.
Nakakura
E K
EK
Department of Cardiothoracic Surgery, Stanford University Medical Center 94305-5247.
McCabe
S M
SM
Zheng
B
B
Shorthouse
R A
RA
Scheiner
T M
TM
Blank
G
G
Jardieu
P M
PM
Morris
R E
RE
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015703:Antigens, CD / Q000276:immunology; D018845:CD11 Antigens; D006085:Graft Survival; D016027:Heart Transplantation; D008212:Lymphocyte Depletion; D016169:Lymphocyte Function-Associated Antigen-1 / Q000032:analysis / Q000276:immunology*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008809:Mice, Inbred C3H; D013601:T-Lymphocytes / Q000502:physiology*; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D015703:Antigens, CD; D018845:CD11 Antigens; D016169:Lymphocyte Function-Associated Antigen-1